All Programs

Use the tool below to view all available Prova Series

Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
CME/CE
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
0.25 credits
- Mazen Noureddin, MD, MHSc
0.25 credits
What’s New in Glaucoma Topical Therapies?
What’s New in Glaucoma Topical Therapies?
MinuteCE®
What’s New in Glaucoma Topical Therapies?
1.00 program credit
- Justin Schweitzer, OD, FAAO
- Sarah H. Van Tassel, MD
1.00 program credit
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Evolving Strategies for Sustained-Release Glaucoma Treatments
Evolving Strategies for Sustained-Release Glaucoma Treatments
MinuteCE®
Evolving Strategies for Sustained-Release Glaucoma Treatments
1.00 program credit
- Sarah H. Van Tassel, MD
- Justin Schweitzer, OD, FAAO
1.00 program credit
3D Heads-Up Visualization: Cases in Glaucoma Surgery
3D Heads-Up Visualization: Cases in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Cases in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
What’s New in Schlemm’s Canal MIGS?
What’s New in Schlemm’s Canal MIGS?
MinuteCE®
What’s New in Schlemm’s Canal MIGS?
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
What’s New in Suprachoroidal MIGS?
What’s New in Suprachoroidal MIGS?
MinuteCE®
What’s New in Suprachoroidal MIGS?
1.00 program credit
- I. Paul Singh, MD
- Paul Petrakos, DO, MS
1.00 program credit
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Effective MIGS for Optimal IOP Control: A Case-Based Approach
MinuteCE®
Effective MIGS for Optimal IOP Control: A Case-Based Approach
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE Live Broadcast
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
May 04, 2025
09:30 PM - 10:30 PM ET
1.00 credit Learn more
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
- Javier Cortes, MD, PhD
- Hope S. Rugo, MD, FASCO
0.50 credits
The Safety of Sodium Oxybate in Treating Narcolepsy
The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CE
The Safety of Sodium Oxybate in Treating Narcolepsy
0.50 credits
- Clete A. Kushida, MD, PhD
- Sally Ibrahim, MD, FAAP
0.50 credits
Molecular Profiling for HER2+ Advanced Solid Tumors
Molecular Profiling for HER2+ Advanced Solid Tumors
CME/CE
Molecular Profiling for HER2+ Advanced Solid Tumors
1.00 credit
- Eric Van Cutsem, MD, PhD
- David SP Tan, MBBS, PhD, PRCP
- James Chih-Hsin Yang, MD, PhD
- Kathleen Moore, MD, MS, FASCO
1.00 credit
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CE
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
0.25 credits
- Jonathan Leventhal, MD
- Shahnaz Singh-Kandah, NP
0.25 credits
Pharmacotherapy in Obesity: Current and Emerging Options
Pharmacotherapy in Obesity: Current and Emerging Options
MinuteCE®
Pharmacotherapy in Obesity: Current and Emerging Options
1.50 program credits
- Donna Ryan, MD
- Andreea Ciudin, MD, PhD
1.50 program credits

All Programs

Popular

Title

Share on ReachMD